Search for: "Jacqueline Berman" Results 1 - 20 of 61
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Patent Transparency for Biologics & Biosimilars: The Revamped Purple Book, BioProcess Online
11 Jul 2021, 10:00 pm
Partners Jacqueline Berman and Jeffrey Gargano and and associates Zachary Miller and Maria Kalousi-Tatum [read post]
Power & Pipes - https://www.morganlewis.com/blogs/powerandpipes
Patent Transparency for Biologics & Biosimilars: The Revamped Purple Book, BioProcess Online
11 Jul 2021, 10:00 pm
Partners Jacqueline Berman and Jeffrey Gargano and and associates Zachary Miller and Maria Kalousi-Tatum [read post]
Well Done - https://www.morganlewis.com/blogs/welldone
Patent Transparency for Biologics & Biosimilars: The Revamped Purple Book, BioProcess Online
11 Jul 2021, 10:00 pm
Partners Jacqueline Berman and Jeffrey Gargano and and associates Zachary Miller and Maria Kalousi-Tatum [read post]
ML BeneBits - https://www.morganlewis.com/blogs/mlbenebits
Patent Transparency for Biologics & Biosimilars: The Revamped Purple Book, BioProcess Online
11 Jul 2021, 10:00 pm
Partners Jacqueline Berman and Jeffrey Gargano and and associates Zachary Miller and Maria Kalousi-Tatum [read post]
Up & Atom - https://www.morganlewis.com/blogs/upandatom
Patent Transparency for Biologics & Biosimilars: The Revamped Purple Book, BioProcess Online
11 Jul 2021, 10:00 pm
Partners Jacqueline Berman and Jeffrey Gargano and and associates Zachary Miller and Maria Kalousi-Tatum [read post]
As Prescribed - https://www.morganlewis.com/blogs/asprescribed
Patent Transparency for Biologics & Biosimilars: The Revamped Purple Book, BioProcess Online
11 Jul 2021, 10:00 pm
Partners Jacqueline Berman and Jeffrey Gargano and and associates Zachary Miller and Maria Kalousi-Tatum [read post]
Tech & Sourcing @ Morgan Lewis - https://www.morganlewis.com/blogs/sourcingatmorganlewis
Congressional Focus Signals Possible Changes for Orphan Drug Approval Process, Clinical Leader
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that [read post]
Power & Pipes - https://www.morganlewis.com/blogs/powerandpipes
Congressional Focus Signals Possible Changes for Orphan Drug Approval Process, Clinical Leader
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that [read post]
Up & Atom - https://www.morganlewis.com/blogs/upandatom
New Guidance From FDA on Postmarket Adverse Event Reporting
2 Apr 2020, 9:00 pm
Kathleen Sanzo, Jacqueline Berman, Michele Buenafe, and Dennis Gucciardo explain the guidance in this [read post]
As Prescribed - https://www.morganlewis.com/blogs/asprescribed
Congressional Focus Signals Possible Changes for Orphan Drug Approval Process, Clinical Leader
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that [read post]
As Prescribed - https://www.morganlewis.com/blogs/asprescribed
Congressional Focus Signals Possible Changes for Orphan Drug Approval Process, Clinical Leader
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that [read post]
Well Done - https://www.morganlewis.com/blogs/welldone
Congressional Focus Signals Possible Changes for Orphan Drug Approval Process, Clinical Leader
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that [read post]
Tech & Sourcing @ Morgan Lewis - https://www.morganlewis.com/blogs/sourcingatmorganlewis
Congressional Focus Signals Possible Changes for Orphan Drug Approval Process, Clinical Leader
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that [read post]
ML BeneBits - https://www.morganlewis.com/blogs/mlbenebits
Questions Surround FDA Orphan Drug Exclusivity Approach, Law360
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how [read post]
As Prescribed - https://www.morganlewis.com/blogs/asprescribed
Questions Surround FDA Orphan Drug Exclusivity Approach, Law360
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how [read post]
Power & Pipes - https://www.morganlewis.com/blogs/powerandpipes
Questions Surround FDA Orphan Drug Exclusivity Approach, Law360
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how [read post]
Tech & Sourcing @ Morgan Lewis - https://www.morganlewis.com/blogs/sourcingatmorganlewis
Questions Surround FDA Orphan Drug Exclusivity Approach, Law360
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how [read post]
Up & Atom - https://www.morganlewis.com/blogs/upandatom
Questions Surround FDA Orphan Drug Exclusivity Approach, Law360
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how [read post]
ML BeneBits - https://www.morganlewis.com/blogs/mlbenebits
Questions Surround FDA Orphan Drug Exclusivity Approach, Law360
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how [read post]
Well Done - https://www.morganlewis.com/blogs/welldone
What Pharma Cos. Must Know About FDA Off-Label Guidance, Law360
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance [read post]
As Prescribed - https://www.morganlewis.com/blogs/asprescribed